| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.18 | 4e-08 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0001 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |